In comparison to the MS group, the BCVA at nadir of our MOG group after ON was significantly worse, whereas the recovery of the visual acuity, defined as the difference between BCVA at nadir and BCVA at the last examination, was significantly better. This evidence concerns the gene MOG and myeloid sarcoma.